HbA1c Cutoff Point and Factors Associated with Foot Complications Among Type 2 Diabetic Patients in an Urban Area
Article Sidebar
Main Article Content
Abstract
Background: The increase in HbA1c levels can lead to severe complications in the feet of type 2 diabetic patients, resulting in physical and psychological losses and reduced quality of life. This study aimed to examine HbA1c levels to prevent and reduce complications. This study aim to study the relationship between HbA1c levels and the severity of Diabetic foot complications in patients with type 2 diabetes in an urban setting.
Study Design: Cross-sectional diagnostic study.
Methods: The study involved 370 participants aged 40 years and older, diagnosed with type 2 diabetes, Data collected included HbA1c levels, ABI and Monofilament test, and personal information. Data were analyzed the corelation with the occurrence of foot complication.
Results: The cutoff values for HbA1c levels associated with foot complications were found to be HbA1c ≥ 7.5% for low severity (Grade 1), HbA1c ≥ 8.0% for moderate severity (Grade 2), and HbA1c ≥ 10.0% for high severity (Grade 3). Factors associated with foot complications included exercise, smoking, and body mass index (BMI).
Conclusions: Diabetic patients who have poorly controlled sugar levels, lack of exercise, smoking, and a high body mass index are affected by the severity of foot complications. Controlling blood sugar levels and educating patients on co-factors can help minimize foot complications.
Keywords: HbA1c, diabetic foot complications
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The content and information in articles published in the PCFM journal are solely the opinions and responsibilities of the authors. The journal's editorial board does not necessarily agree with or share any responsibility for them.
All articles, information, content, images, etc., published in the PCFM journal are the copyright of the PCFM journal. If any individual or organization wishes to reproduce, distribute, or use any part or the entirety of the content, they must obtain written permission from the PCFM journal beforehand.
References
Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203-34.
Sakboonyarat B, Sangkool T, Poovieng J, Jongcherdchootrakul K, Srisawat P, Hatthachote P, et al. Trends in the prevalence of type 2 diabetes among Royal Thai Army personnel and associated factors from 2017 to 2021. J Southeast Asian Med Res. 2023;7:e0160.
Hossain MA, Sarkar MK, Mahbub I, Islam SMS. A study on peripheral neuropathy and its related risk factors associated with HbA1c levels. J Biosci (Rajshari). 2021;29:123-38.
Jalilian M, Ahmadi Sarbarzeh P, Oubari S. Factors related to severity of diabetic foot ulcer: A systematic review. Diabetes Metab Syndr Obes. 2020;13: 1835-42.
สมาคมโรคเบาหวานแห่งประเทศไทย ในพระบรมราชูปถัมภ์สมเด็จพระเทพรัตนราชสุดาฯ สยามบรมราชกุมารี. แนวทางเวชปฏิบัติสำหรับโรคเบาหวาน 2566. กรุงเทพมหานคร: บริษัท ศรีเมืองการพิมพ์; 2566.
Fawzy MS, Alshammari MA, Alruwaili AA, Alanazi RTR, Alharbi JAM, Almasoud AMR, et al. Factors associated with diabetic foot among type 2 diabetes in Northern area of Saudi Arabia: a descriptive study. BMC Res Notes. 2019;12(1):51. PubMed PMID: 30670095
Hamida A, Irfana L, Irawati DN. Correlation of HbA1c levels and diabetic neuropathy complications in diabetes mellitus patients. Gac Med Caracas. 2021; 129(s2):S293-8.
Din N, Khan M, Danyal Khan B, Ghaffar T, Tabish Ikram M, Aamir Salman M, et al. Association of diabetic foot ulcer with glycated hemoglobin A1C levels: Diabetic foot ulcer with glycated HbA1C levels. Pakistan Journal of Health Sciences. 2023;???:161-5.
Su J-B, Zhao L-H, Zhang X-L, Cai H-L, Huang H-Y, Xu F, et al. HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients. Cardiovasc Diabetol. 2018;17(1):47. PubMed PMID: 29598819
Moodley RM, D’Almeida SS, Lameko V, Ghimire S. Novel relationship between hemoglobin A1c levels and foot ulcer development among patients with type 2 diabetes mellitus admitted at Tupua Tamasese Meaole Hospital. Cureus. 2021;13(11):e20054. PubMed PMID: 34993030
Limsomwong P, Wajanakomkul P. Prevalence and factors associated with the stratified risk to develop diabetic foot ulcer in type 2 diabetes mellitus patients in primary care unit of Songklanagarind Hospital. J Med Assoc Thai. 2023;106:434-43.
Kelsey JL. Methods in Observational Epidemiology. 2nd edition. Oxford: Oxford University Press; 1996.
Farooque U, Lohano AK, Hussain Rind S, Rind MS, Karimi S, Jaan A, et al. Correlation of hemoglobin A1c 7 with Wagner classification in patients with diabetic foot. Cureus. 2020;12(7): e9199. PubMed PMID: 32821554
Lai YR, Chiu WC, Huang CC, Tsai NW, Wang HC, Lin WC, et al. HbA1C variability is strongly associated with the severity of peripheral neuropathy in patients with type 2 diabetes. Front Neurosci. 2019; 13:90. PubMed PMID: 30814926
Nozawa K, Ikeda M, Kikuchi S. Association between HbA1c levels and diabetic peripheral neuropathy: A case control study of patients with type 2 diabetes using claims data. Drugs Real World Outcomes. 2022;9:403-14.
Liu X, Xu Y, An M, Zeng Q. The risk factors for diabetic peripheral neuropathy: A meta-analysis. PLoS One.2019;14(2):e0212574. PubMed PMID: 30785930
Maiya AG, Parameshwar A, Hande M, Nandalike V. Relationship between glycated hemoglobin and vibration perception threshold in diabetic peripheral neuropathy. Int J Low Extrem Wounds. 2020;19:120-4.
Casadei G, Filippini M, Brognara L. Glycated hemoglobin (HbA1c) as a biomarker for diabetic foot peripheral neuropathy. Diseases. 2021;9(1):16. PubMed PMID: 33671807
Vahwere BM, Ssebuufu R, Namatovu A, Kyamanywa P, Ntulume I, Mugwano I, et al. Factors associated with severity and anatomical distribution of diabetic foot ulcer in Uganda: a multicenter cross-sectional study. BMC Public Health. 2023;23(1):463. PubMed PMID: 36899359
Matos M, Mendes R, Silva AB, Sousa N. Physical activity and exercise on diabetic foot related outcomes: A systematic review. Diabetes Res Clin Pract. 2018;139:81-90.
Syauta D, Mulawardi, Prihantono, Hendarto J, Mariana N, Sulmiati, et al. Risk factors affecting the degree of diabetic foot ulcers according to Wagner classification in diabetic foot patients. Medicina Clínica Práctica. 2021;4(100231):100231.
อำภาภรณ์ นามวงศ์พรหม, น้ำอ้อย ภักดีวงศ์. การเกิดแผลที่เท้าและปัจจัยที่มีความสัมพันธ์กับการเกิดแผลที่เท้าของผู้เป็นเบาหวานชนิดที่ 2. วารสารสภาการพยาบาล. 2553; 25:51-63.
